Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sanofi Ord Shs SNYNF

Healthcare
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:SNYNF)

Biond Biologics and Sanofi Enter into Global Licensing Agreement for BND-22, a Novel Immune Checkpoint Inhibitor Targeting the ILT2 Receptor

PR Newswire January 12, 2021

Sanofi Wins Prestigious Drug Discovery Award for Innovative Rare Blood Clotting Disorder Treatment[1]

PR Newswire December 17, 2019

Sanofi Announces Licensing of Dupixent® ? (dupilumab) in the EU for the Treatment of Severe Asthma With Type 2 Inflammation[1]

PR Newswire May 8, 2019

Regeneron and Sanofi Announce Approval of DUPIXENT® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union

PR Newswire September 28, 2017

What's Next For L'Oreal After The Death Of Billionaire Liliane Bettencourt?

Benzinga.com  September 22, 2017

Sanofi and NIH researchers develop "three-in-one" antibodies as a potential breakthrough intervention for HIV/AIDS

PR Newswire September 20, 2017

Alnylam Pharmaceutical Surges After Rare Disease Drug Meets Key Endpoints

Benzinga.com  September 20, 2017

Alnylam and Sanofi Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy

Business Wire September 20, 2017

Huge Supply Shortage Looms for Canada's Newest Industry

PR Newswire September 19, 2017
View More News ››

Opinion & Analysis (OTCPK:SNYNF)

ECB interest rate cuts and bond buying boosts ETFs

Benzinga.com  September 5, 2014

Stock market profits can make you complacent

Amber Lee Mason and Brian Hunt June 23, 2014

Everyone gets the flu

Marc Lichtenfeld March 6, 2013

Big Pharma has a big problem and merger mania is heating up

Marc Lichtenfeld July 29, 2010
View More Opinion ››

Bullboard Posts (OTCPK:SNYNF)

Press Release: Sarclisa recommended for EU approval by the C

JUST IN: $SNYNF Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple...
whytestocks - 9 days ago

Press Release: Sanofi and Biovac spearhead polio vaccine man

News; $SNYNF Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in AfricaSanofi and Biovac spearhead...
whytestocks - June 20, 2024

Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sal

Breaking News: $SNY Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings | BenzingaThursday,@Sanofi SA@...
whytestocks - April 25, 2024

Sanofi and Covid19? WPD Pharma...

Sanofi could easily buy WPD Pharma, who develop a Covid19-drug called WP1122. Did you read this? https://www.globenewswire.com/news...
Blocky - January 8, 2021

Happy new year Do your Own DD

https://www.globenewswire.com/news-release/2020/12/31/2151927/0/en/MedMira-Announces-Product-Update.html
Rossaporino - January 2, 2021

Bonvoyage12.....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020
View more Bullboard ››

Lahontan Gold Corp.

Lahontan Gold Corp.

Lahontan Gold Corp. is a Canada-based mineral exploration company. The Company is engaged in the identification, acquisition, ...
View More »